Literature DB >> 20847819

High-Mobility Group A (HMGA) Proteins and Breast Cancer.

Silvia Peluso1, Gennaro Chiappetta.   

Abstract

The high-mobility group A (HMGA) protein family includes HMGA1a, HMGA1b and HMGA1c, which are encoded by the same gene through alternative splicing, and the closely related HMGA2 protein. HMGA proteins have been found to be abundant in several malignant neoplasias, including colorectal, prostate, cervical, lung, thyroid and breast carcinoma. HMGA proteins can be ideal candidates for the identification of new prognosis and diagnosis factors with non-invasive methods. To provide some clarity regarding the abundance of articles on this topic, here we focus on the relationship between HMGA proteins and breast cancer and their clinical perspective in the development of new therapeutic strategies.

Entities:  

Year:  2010        PMID: 20847819      PMCID: PMC2931040          DOI: 10.1159/000297717

Source DB:  PubMed          Journal:  Breast Care (Basel)        ISSN: 1661-3791            Impact factor:   2.860


  36 in total

1.  Revised nomenclature for high mobility group (HMG) chromosomal proteins.

Authors:  M Bustin
Journal:  Trends Biochem Sci       Date:  2001-03       Impact factor: 13.807

2.  Tumour-specific distribution of BRCA1 promoter region methylation supports a pathogenetic role in breast and ovarian cancer.

Authors:  T Bianco; G Chenevix-Trench; D C Walsh; J E Cooper; A Dobrovic
Journal:  Carcinogenesis       Date:  2000-02       Impact factor: 4.944

3.  BRCA2 hereditary breast cancer pathophenotype.

Authors:  J N Marcus; P Watson; D L Page; S A Narod; P Tonin; G M Lenoir; O Serova; H T Lynch
Journal:  Breast Cancer Res Treat       Date:  1997-07       Impact factor: 4.872

4.  Inhibition of HMGI-C protein synthesis suppresses retrovirally induced neoplastic transformation of rat thyroid cells.

Authors:  M T Berlingieri; G Manfioletti; M Santoro; A Bandiera; R Visconti; V Giancotti; A Fusco
Journal:  Mol Cell Biol       Date:  1995-03       Impact factor: 4.272

5.  Enhancement of serum-response factor-dependent transcription and DNA binding by the architectural transcription factor HMG-I(Y).

Authors:  M T Chin; A Pellacani; H Wang; S S Lin; M K Jain; M A Perrella; M E Lee
Journal:  J Biol Chem       Date:  1998-04-17       Impact factor: 5.157

6.  Detection of tumor messenger RNA in the serum of patients with malignant melanoma.

Authors:  M S Kopreski; F A Benko; L W Kwak; C D Gocke
Journal:  Clin Cancer Res       Date:  1999-08       Impact factor: 12.531

7.  HMGA1 protein overexpression in human breast carcinomas: correlation with ErbB2 expression.

Authors:  Gennaro Chiappetta; Gerardo Botti; Mario Monaco; Rosa Pasquinelli; Francesca Pentimalli; Maurizio Di Bonito; Giuseppe D'Aiuto; Monica Fedele; Rodolfo Iuliano; Emiliano A Palmieri; Giovanna Maria Pierantoni; Vincenzo Giancotti; Alfredo Fusco
Journal:  Clin Cancer Res       Date:  2004-11-15       Impact factor: 12.531

Review 8.  The HMGA proteins: a myriad of functions (Review).

Authors:  Isabelle Cleynen; Wim J M Van de Ven
Journal:  Int J Oncol       Date:  2008-02       Impact factor: 5.650

9.  Genetic analysis of breast cancer in the cancer and steroid hormone study.

Authors:  E B Claus; N Risch; W D Thompson
Journal:  Am J Hum Genet       Date:  1991-02       Impact factor: 11.025

10.  SAR-dependent mobilization of histone H1 by HMG-I/Y in vitro: HMG-I/Y is enriched in H1-depleted chromatin.

Authors:  K Zhao; E Käs; E Gonzalez; U K Laemmli
Journal:  EMBO J       Date:  1993-08       Impact factor: 11.598

View more
  13 in total

1.  Biomarkers for Early Cancer Detection - Methodological Aspects.

Authors:  Paolo Verderio; Anita Mangia; Chiara M Ciniselli; Paola Tagliabue; Angelo Paradiso
Journal:  Breast Care (Basel)       Date:  2010-04-21       Impact factor: 2.860

2.  Candidate agents for papillary thyroid cancer identified by gene expression analysis.

Authors:  Wei Zhu; Chen Li; Zhilong Ai
Journal:  Pathol Oncol Res       Date:  2013-03-22       Impact factor: 3.201

3.  Silencing of HMGA1 expression by RNA interference suppresses growth of osteogenic sarcoma.

Authors:  Shaohui Yuan; Qi Pan; Chunjiang Fu; Zhenggang Bi
Journal:  Mol Cell Biochem       Date:  2011-05-15       Impact factor: 3.396

4.  Knockdown of HMGA1 inhibits human breast cancer cell growth and metastasis in immunodeficient mice.

Authors:  Francescopaolo Di Cello; James Shin; Kirsten Harbom; Cory Brayton
Journal:  Biochem Biophys Res Commun       Date:  2013-03-29       Impact factor: 3.575

5.  SOX4 overexpression is a novel biomarker of malignant status and poor prognosis in breast cancer patients.

Authors:  Guo-Dong Song; Yu Sun; Hong Shen; Wei Li
Journal:  Tumour Biol       Date:  2015-01-16

6.  Dysregulated protease activated receptor 1 (PAR1) promotes metastatic phenotype in breast cancer through HMGA2.

Authors:  E Yang; J Cisowski; N Nguyen; K O'Callaghan; J Xu; A Agarwal; A Kuliopulos; L Covic
Journal:  Oncogene       Date:  2015-07-13       Impact factor: 9.867

Review 7.  High Mobility Group Proteins in Sepsis.

Authors:  Guibin Liang; Zhihui He
Journal:  Front Immunol       Date:  2022-06-02       Impact factor: 8.786

8.  Genetic Characterization of Myoid Hamartoma of the Breast.

Authors:  Ioannis Panagopoulos; Ludmila Gorunova; Hege Kilen Andersen; Thomas Dahl Pedersen; Jon Lømo; Marius Lund-Iversen; Francesca Micci; Sverre Heim
Journal:  Cancer Genomics Proteomics       Date:  2019 Nov-Dec       Impact factor: 4.069

9.  WNT10B/β-catenin signalling induces HMGA2 and proliferation in metastatic triple-negative breast cancer.

Authors:  Peter Wend; Stephanie Runke; Korinna Wend; Brenda Anchondo; Maria Yesayan; Meghan Jardon; Natalie Hardie; Christoph Loddenkemper; Ilya Ulasov; Maciej S Lesniak; Rebecca Wolsky; Laurent A Bentolila; Stephen G Grant; David Elashoff; Stephan Lehr; Jean J Latimer; Shikha Bose; Husain Sattar; Susan A Krum; Gustavo A Miranda-Carboni
Journal:  EMBO Mol Med       Date:  2013-01-11       Impact factor: 12.137

10.  Identification of proteins responsible for adriamycin resistance in breast cancer cells using proteomics analysis.

Authors:  Zhipeng Wang; Shuang Liang; Xin Lian; Lei Liu; Shu Zhao; Qijia Xuan; Li Guo; Hang Liu; Yuguang Yang; Tieying Dong; Yanchen Liu; Zhaoliang Liu; Qingyuan Zhang
Journal:  Sci Rep       Date:  2015-03-30       Impact factor: 4.996

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.